Smoking Cessation

Smoking cessation refers to medicines and supportive products intended to help people stop using tobacco and other nicotine-containing products. This category groups together pharmacological options that reduce nicotine cravings, ease withdrawal symptoms, or alter the brain pathways associated with nicotine dependence. Items range from over-the-counter nicotine replacements to prescription pharmaceuticals developed specifically to aid cessation efforts, and they are commonly offered alongside non-drug supports such as counseling or behavioral programs.

Common use cases include quitting smoking completely, reducing cigarette consumption as an intermediate step, and preventing relapse after a quit attempt. Some people use these medicines to manage acute cravings during the first weeks after stopping, while others may take a prescribed course that begins before a planned quit date and continues for a set treatment period. These products are also used in combination with structured support services to address both physical dependence and habitual or behavioral aspects of smoking.

Types of medications in this category include nicotine replacement therapies (NRT) — such as patches, gum, lozenges and inhalers — which provide controlled doses of nicotine without the harmful combustion products of smoking. Prescription non-nicotine options are also available; for example, varenicline is a targeted treatment that acts on specific brain receptors involved in nicotine reward, and bupropion is an antidepressant that has been repurposed for smoking cessation in certain formulations. Some well-known names associated with these approaches are varenicline (often known by the name Champix in some markets) and bupropion-containing products (sold under various names including Wellbutrin, Wellbutrin SR and Zyban in different formulations and indications).

How these medicines are used varies by product. Nicotine replacement products usually provide a steady or on-demand nicotine dose to ease withdrawal, while prescription agents typically follow a defined administration schedule or course prescribed by a clinician. Some people combine a longer-acting option with a short-acting product to manage breakthrough urges. Sustained-release formulations exist for certain medicines to allow less frequent dosing. Product packaging and official prescribing information describe intended use patterns and treatment durations for each option.

General safety considerations are an important part of choosing among smoking cessation medicines. Each medicine has a distinct profile of common adverse effects and may have specific contraindications or cautions noted in regulatory information. Factors such as coexisting medical conditions, other medications being taken, pregnancy and breastfeeding status can affect suitability. Product leaflets and regulatory guidance provide information about possible side effects, warnings and monitoring recommendations, and pathways for reporting adverse events are established in most countries.

When people compare options they typically consider effectiveness, expected side effects, mode of administration (patch, gum, lozenge, inhaler, or oral tablet), dosing convenience and whether a product is available over the counter or requires a prescription. Other factors include whether a formulation is immediate or sustained release, how it fits with daily routines, and whether complementary supports such as counseling are available. Reading official product information and reviewing the range of available formulations can help users identify the attributes most relevant to their preferences and needs.